Literature DB >> 11594449

Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test.

T Anraku1, Y Ikegaya, N Matsuki, N Nishiyama.   

Abstract

RATIONALE: Opiate-dependent subjects experience severe depression as one of the subjective symptoms during withdrawal. No experimental work, however, has focused on the ability of opiate-withdrawal to produce depression-like behavior in dependent animal. OBJECTIVES. We therefore investigated whether withdrawal from chronic morphine treatment affects immobility in forced swimming test in rats.
METHODS: Morphine was administered in a dose escalation fashion using doses ranging from 20 to 140 mg/kg twice daily for 14 days, followed by 1-6 days of withdrawal, and their duration of immobility was assessed.
RESULTS: After the last morphine treatment. an increase in immobility occurred late on day 3 and persisted to at least day 6 of withdrawal without any change in ambulatory activity.
CONCLUSIONS: The results suggest that the morphine withdrawal resulted in prolonged enhancement of depression-like behavior in drug-dependent laboratory animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594449     DOI: 10.1007/s002130100793

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.

Authors:  Giovanna Piras; Maria A Piludu; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2013-07-30       Impact factor: 4.530

2.  Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Authors:  Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls
Journal:  Neuroscience       Date:  2018-06-27       Impact factor: 3.590

Review 3.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

4.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

5.  A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.

Authors:  P E Lutz; D Reiss; A M Ouagazzal; B L Kieffer
Journal:  Behav Brain Res       Date:  2013-01-04       Impact factor: 3.332

6.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

7.  Long-lasting effects of adolescent oxycodone exposure on reward-related behavior and gene expression in mice.

Authors:  Victoria Sanchez; Marco D Carpenter; Nicole L Yohn; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

8.  Sex differences in affective response to opioid withdrawal during adolescence.

Authors:  Stephen R Hodgson; Rebecca S Hofford; Kris W Roberts; Dvora Eitan; Paul J Wellman; Shoshana Eitan
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

Review 9.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

10.  Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.

Authors:  Pierre-Eric Lutz; Gulebru Ayranci; Paul Chu-Sin-Chung; Audrey Matifas; Pascale Koebel; Dominique Filliol; Katia Befort; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-05-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.